Predict your next investment

Nucleonics company logo
HEALTHCARE | Pharmaceutical Distribution & Wholesale
nucleonicsinc.com

See what CB Insights has to offer

Founded Year

2001

Stage

Series B | Alive

Total Raised

$50.8M

Last Raised

$49.2M | 17 yrs ago

About Nucleonics

Nucleonics is developing a method of RNA interference to silence disease-causing genes. Initially, the company is applying its technology to develop expressed interfering RNA (eiRNA) therapies for the treatment of chronic Hepatitis B and Hepatitis C viral infections.

Nucleonics Headquarter Location

13 Summit Square Center Suite 305

Langhorne, Pennsylvania, 19047,

United States

866-268-3471

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Nucleonics Patents

Nucleonics has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/22/2004

5/5/2009

Transcription factors, Molecular biology, Gene expression, Human proteins, Biotechnology

Grant

Application Date

4/22/2004

Grant Date

5/5/2009

Title

Related Topics

Transcription factors, Molecular biology, Gene expression, Human proteins, Biotechnology

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.